Our Why

“We are leveraging our cutting-edge science to develop lifesaving and life altering therapies for patients with rare immunological diseases.”

Søren Tulstrup, President and CEO

 

Latest news

Stockholm -1.60 HNSA   257.60 SEK
 
16Jun

Citi's European Healthcare Conference

London (virtual)
23Jun

Annual General Meeting

16Jul

Interim report for Jan - Jun. 2020

16Sep

BofAML Global Healthcare Conference

London
17Sep

BofAML Global Healthcare Conference

London
22Oct

Interim report for Jan - Sep 2020

Introduction to Hansa

Søren Tulstrup, President & CEO


Hansa in brief
left-photo-mask

Join Hansa

From our headquarters in Lund, Sweden, we reach around the world. Our dedicated team includes experienced and courageous specialists driven by our purpose to develop lifesaving and life altering therapies for patients living with rare immunological diseases.

Since our founding in 2007, we have worked in cross functional and agile teams. We are gender-balanced, comprise 14 different nationalities and see diversity as an enabler for reaching our corporate objectives. The recruitment of highly motivated, experienced and talented team players supports our development towards a fully integrated global biopharmaceutical company.

Careers